Effects of experimental conditions on solubility measurements for BCS classification in order to improve the biowaiver guidelines
DOI:
https://doi.org/10.1590/s2175-979020200004181083Keywords:
Solubility. Shake-flask. Effects. Propranolol hydrochloride. Nimesulide.Abstract
Among the methods described for determining the solubility, shake-flask is suitable to evaluate the equilibrium solubility according to the BCS. Nevertheless, experimental conditions related to the shake-flask method are not well described. Evaluating the effects of experimental conditions on solubility measurements by shake-flask method is important and contributes in biowaiver decision. For this work, propranolol hydrochloride and nimesulide were used as model compound of high and low solubility, respectively. Equilibrium solubility was evaluated at 37 ºC, 100 rpm during 48 hours in buffer media. Effects of the rotation speed, temperature, substance in excess and aliquot withdrawn were evaluated. Small variations of temperature caused significant differences in the solubility and then this parameter must be controlled. Excess of raw material influenced the results of the nimesulide, then, little excess is recommended. Rotation speed did not cause differences in the equilibrium solubilities, but at 150 rpm the equilibrium was reached faster. Aliquot did not present significant differences, but excessive withdrawn should be avoided. Therefore, the evaluation of equilibrium solubility using shake-flask method must be performed in physiological pH conditions, 37 ± 1 ºC, substance in excess 10% above saturation, 50, 100 or 150 rpm and aliquot withdrawn not more than 10% of the media volume.
Downloads
References
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413-420.
Avdeef A, Berger CM, Brownell C. pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharm Res. 2000;17(1):85-89.
Avdeef A. Absorption and drug development solubility, permeability, and charge state. New Jersey: Wiley-Interscience; 2003.
Avdeef A. Suggested improvements for measurement of equilibrium solubility-pH of ionizable drugs. ADMET & DMPK. 2015;3(2):84-109.
Avdeef A, Fuguet E, Llinàs A, Ràfols C, Bosch E, Völgyi G, Verbić T, et al. Equilibrium solubility measurement of ionizable drugs - consensus recommendations for improving data quality. ADMET & DMPK. 2016;4(2):117-178.
Baka E, Comer JE, Takacs-Novak K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46(2):335-341.
BRASIL. Resolução da Diretoria Colegiada - RDC nº37, de 3 de agosto de 2011. “Dispõe sobre o guia para isenção e substituição de estudos de biodisponibilidade relativa/ bioequivalência e dá outras providências.” Available from: <http://portal.anvisa.gov.br/documents/33880/2568070/rdc0037_03_08_2011.pdf/13c41657-e93b-4d09-99eb377f760f3aa0>. Accessed on 01 January 2018.
BRASIL. Resolução da Diretoria Colegiada - RDC nº167, de 24 de julho de 2017. “Dispõe sobre a aprovação do 2º
Patrícia Fernanda Monteiro, Neila Márcia Silva-Barcellos, Tamires Guedes Caldeira, Suplemento da Farmacopeia Brasileira, 5ª edição.” Available from: <http://portal.anvisa.gov.br/documents/33832/259143/Segundo+Suplemento+FB+5/9cfb1239-875c-4a77-8741b59416684d29>. Accessed on 05 July 2018.
Dellis D, Giaginis C, Tsantili-Kakoulidou A. Physicochemical profile of nimesulide: Exploring the interplay of lipophilicity, solubility and ionization. J Pharm Biomed Anal. 2007;44(1): 57-62.
European Medicines Agency. EMA. Guideline on the investigations of bioequivalence. London, United Kingdom, 2010. 25 p. Available from: <http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf>. Accessed on 01 January 2018.
» http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/ WC500070039.pdf
Food and Drug Administration. FDA. Waiver of in vivo bioavailability and bioequivalence studies for immediaterelease solid oral dosage forms base on a Biopharmaceutics Classification System. Maryland, EUA, 2017. 19 p. Available from: <https://www.fda.gov/downloads/Drugs/Guidances/ucm070246.pdf>. Accessed on 01 January 2018.
» https://www.fda.gov/downloads/Drugs/Guidances/ucm070246.pdf
Glomme A, März J, Dressman JB. Comparison of a miniaturized shake-flask solubility method with automated potenciometric acid/base titrations and calculated solubilities. J Pharm Sci. 2005 Jan;94(1):1-16.
Gonsalves ADA, Araújo CRM, Filho CAL, Medeiros FS. Contextualizando reações ácido-base de acordo com a teoria protônica de Brönsted-Lowry usando comprimidos de propranolol e nimesulida. Quim Nova. 2013;36(8):1236-1241.
Heikkila T, Karjalainena M, Ojala K, Partola K, Lammert F, Augustijns P, et al. Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid. Int J Pharm. 2011;405(1-2):132-136.
Kawakami K, Miyoshi K, Ida Y. Impact of the amount of excess solids on apparent solubility. Pharm Res. 2005;22(9): 1537-1543.
Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2): 265-278.
Liu H, Wanga P, Zhang X, Shenc F, Gogos CG. Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit® E PO solid dispersions. Int J Pharm. 2010;383(1-2):161-169.
Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol. 2002;42(6):620-643.
Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:1-10.
Silva RLD, Volpato NM. Meios para dissolução de comprimidos de nimesulida: ação dos tensoativos. Rev Bras Cienc Farm. 2002;38(2):163-172.
Takács-Novák K, Szöke V, Völgyi G, Horváth P, Ambrus R, Szabó-Révész P. Biorelevant solubility of poorly soluble drugs: Rivaroxaban, furosemide, papaverine and niflumic acid. J Pharm Biomed Anal. 2013;83:279-285.
Treptow RS. Le Châtelier’s principle applied to the temperature dependence of solubility. J Chem Educ. 1984;61(6):499.
United States Pharmacopeia 37 ed. Rockville: United States Pharmacopeial Convention, 2014.
Vogelpoel H, Welink J, Amidon GL, Junginger HE, Midha KK, Möller H, et al. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci. 2004;93(8):1945-1956.
Volgyi G, Baka E, Kovács M, Takácsné NK. Good laboratory practice of equilibrium solubility measurement II. Study of pH-dependent solubility of ionizable compounds. Acta Pharm Hung. 2011;81(2):87-95.
Wang H, Zou G, Wan ATK. Adaptive LASSO for varyingcoefficient partially linear measurement error models. J Stat Plan Inference. 2013;143(1):40-54.
World Health Organization. WHO. Expert Committee on Specifications for Pharmaceutical Preparations. Geneva, Switzerland, 2015. 188 p. Available from: <http://apps.who.int/iris/bitstream/10665/81144/1/WHO_TRS_981_eng.pdf>. Accessed on 01 January 2018.
» http://apps.who.int/iris/bitstream/10665/81144/1/WHO_TRS_981_eng.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
